Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
De-Yu Ma, Han-Yu Huang, Hua Zou, Meng-Lu Wu, Qiu-Xia Lin, Bo Liu & Shi-Feng Huang. (2020) Carbapenem-Resistant Klebsiella aerogenes Clinical Isolates from a Teaching Hospital in Southwestern China: Detailed Molecular Epidemiology, Resistance Determinants, Risk Factors and Clinical Outcomes. Infection and Drug Resistance 13, pages 577-585.
Read now
Read now
Articles from other publishers (21)
Tsz Hin Ng, Jing J. Zhao, Ryan Gumbleton, Shannon Olson, Stephanie Smith & Marco R. Scipione. (2023)
Treatment Outcomes for Carbapenem-Resistant and Cephalosporin-Susceptible
Pseudomonas aeruginosa
Pneumonia
. Annals of Pharmacotherapy.
Crossref
Crossref
Prity Rani Deshwal, Muskan Aggarwal, Nalla Surender Reddy, Raisa Fathima & Pramil Tiwari. (2023) Association of β-lactam antimicrobial's exposure with carbapenem-resistant Pseudomonas aeruginosa infection: a cumulative meta-analysis. Global Health Journal 7:3, pages 137-146.
Crossref
Crossref
Alecks Megxel S. Abordo, Mark B. Carascal, Roland Remenyi, Doralyn S. Dalisay & Jonel P. Saludes. (2023) Clinically Isolated β-Lactam-Resistant Gram-Negative Bacilli in a Philippine Tertiary Care Hospital Harbor Multi-Class β-Lactamase Genes. Pathogens 12:8, pages 1019.
Crossref
Crossref
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, Amy J Mathers, David van Duin & Cornelius J Clancy. (2023) Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clinical Infectious Diseases.
Crossref
Crossref
Kasim Allel, Jennifer Stone, Eduardo A. Undurraga, Lucy Day, Catrin E. Moore, Leesa Lin, Luis Furuya-Kanamori & Laith Yakob. (2023) The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis. PLOS Medicine 20:6, pages e1004199.
Crossref
Crossref
Qing Yuan, Lei Guo, Bin Li, Sheng Zhang, Haiting Feng, Yan Zhang, Meihong Yu, Hangbin Hu, Hongchao Chen, Qing Yang & Tingting Qu. (2023) Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study. Frontiers in Microbiology 14.
Crossref
Crossref
Drew A. Wells, Asia J. Johnson, Jack G. Lukas, Darius Mason, Kerry O. Cleveland, Aaron Bissell & Athena L.V. Hobbs. (2022) Criteria Restricting Inappropriate Meropenem Empiricism (CRIME): a quasi-experimental carbapenem restriction pilot at a large academic medical centre. International Journal of Antimicrobial Agents 60:4, pages 106661.
Crossref
Crossref
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, Amy J Mathers, David van Duin & Cornelius J Clancy. (2022)
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and
Pseudomonas aeruginosa
with Difficult-to-Treat Resistance (DTR-
P. aeruginosa
)
. Clinical Infectious Diseases 75:2, pages 187-212.
Crossref
Crossref
Cheng Len Sy, Pao-Yu Chen, Chun-Wen Cheng, Ling-Ju Huang, Ching-Hsun Wang, Tu-Hsuan Chang, Yi-Chin Chang, Chia-Jung Chang, Ing-Moi Hii, Yu-Lung Hsu, Ya-Li Hu, Pi-Lien Hung, Chen-Yen Kuo, Pei-Chin Lin, Po-Yen Liu, Ching-Lung Lo, Shih-Hao Lo, Pei-Ju Ting, Chien-Fang Tseng, Hsiao-Wei Wang, Ching-Hsiang Yang, Susan Shin-Jung Lee, Yao-Shen Chen, Yung-Ching Liu & Fu-Der Wang. (2022) Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms. Journal of Microbiology, Immunology and Infection 55:3, pages 359-386.
Crossref
Crossref
Yu-Lin Lee, Wen-Chien Ko & Po-Ren Hsueh. (2022) Geographic Patterns of Carbapenem-Resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015–2019. Antimicrobial Agents and Chemotherapy 66:2.
Crossref
Crossref
Ana Paula Streling, Rodrigo Cayô, Carolina S. Nodari, Luiz G.P. Almeida, Fernanda F. Santos, Blake Hanson, An Q. Dinh, Ana Tereza R. Vasconcelos, Willian R. Miller, Cesar A. Arias & Ana C. Gales. (2021) Genomic analysis of carbapenem-resistant Pseudomonas aeruginosa ST143 clone showing susceptibility to broad-spectrum cephalosporins. Journal of Global Antimicrobial Resistance 26, pages 177-179.
Crossref
Crossref
Aya Ishii, Katsumi Shigemura, Koichi Kitagawa, Mizuki Harada, Yuki Kan, Fuka Hayashi, Kayo Osawa, K. Kuntaman, Toshiro Shirakawa & Masato Fujisawa. (2021) Cross-Resistance and the Mechanisms of Cephalosporin-Resistant Bacteria in Urinary Tract Infections Isolated in Indonesia. Current Microbiology 78:5, pages 1771-1777.
Crossref
Crossref
Yee-Huang Ku & Wen-Liang Yu. (2021) Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?. Infection, Genetics and Evolution 88, pages 104707.
Crossref
Crossref
Payam Behzadi, Zoltán Baráth & Márió Gajdács. (2021) It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics 10:1, pages 42.
Crossref
Crossref
Gleyce Hellen de Almeida de Souza, Luana Rossato, Gabriel Teixeira Brito, Graciela Mendonça dos Santos Bet & Simone Simionatto. (2021) Carbapenem-resistant Pseudomonas aeruginosa strains: a worrying health problem in intensive care units. Revista do Instituto de Medicina Tropical de São Paulo 63.
Crossref
Crossref
Li Yan, Jide Sun, Xiuyu Xu & Shifeng Huang. (2020) Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital. Antimicrobial Resistance & Infection Control 9:1.
Crossref
Crossref
Ana D. Vega, Adriana Jimenez, Gemma Rosello, Kimberly C. Claeys, Octavio V. Martinez, Biagio De Pascale, Armando Perez-Cardona & Lilian Abbo. (2020) Implementing carbapenem-resistance testing algorithms for Enterobacteriales and Pseudomonas aeruginosa: diagnostic and antimicrobial stewardship with timely infection prevention. Diagnostic Microbiology and Infectious Disease 97:4, pages 115069.
Crossref
Crossref
M. V. K. S. Wickramanayake, P. S. Dahanayake, Sabrina Hossain, Mahanama De Zoysa & Gang-Joon Heo. (2020) Aeromonas spp. Isolated from Pacific Abalone (Haliotis discus hannai) Marketed in Korea: Antimicrobial and Heavy-Metal Resistance Properties. Current Microbiology 77:8, pages 1707-1715.
Crossref
Crossref
Márió Gajdács. (2020) Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing. Antibiotics 9:4, pages 153.
Crossref
Crossref
Kesia Esther da Silva, Stephen Baker, Julio Croda, To Nguyen Thi Nguyen, Christine J. Boinett, Leticia Spanivello Barbosa, Andyane Tetila & Simone Simionatto. (2020) Risk factors for polymyxin-resistant carbapenemase-producing Enterobacteriaceae in critically ill patients: An epidemiological and clinical study. International Journal of Antimicrobial Agents 55:3, pages 105882.
Crossref
Crossref
Younes Khalili, Mina Yekani, Hamid Reza Goli & Mohammad Yousef Memar. (2019) Characterization of carbapenem-resistant but cephalosporin-susceptible Pseudomonas aeruginosa. Acta Microbiologica et Immunologica Hungarica 66:4, pages 529-540.
Crossref
Crossref